PetVivo Holdings, Inc. (PETV)

Market Cap	30.08M +77.0%
Revenue (ttm)	1.14M +0.8%
Net Income	-10.47M
EPS	-0.35
Shares Out	37.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,100
Open	0.7700
Previous Close	0.8000
Day's Range	0.7700 - 0.8000
52-Week Range	0.6000 - 1.6900
Beta	1.24
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 29, 2026

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 22
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In fiscal year 2026, PetVivo Holdings's revenue was $1.14 million, an increase of 0.80% compared to the previous year's $1.13 million. Losses were -$10.47 million, 24.7% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error